Adage Capital Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-37,500
| Closed | -$2.63M | – | 882 |
|
|
2024
Q1 | $2.63M | Buy |
37,500
+7,500
| +25% | +$526K | 0.01% | 757 |
|
|
2023
Q4 | $2.5M | Buy |
+30,000
| New | +$2.5M | 0.01% | 732 |
|
|
2021
Q3 | – | Sell |
-711,407
| Closed | -$14.1M | – | 1031 |
|
|
2021
Q2 | $14.1M | Sell |
711,407
-838,593
| -54% | -$16.6M | 0.03% | 588 |
|
|
2021
Q1 | $36.1M | Buy |
+1,550,000
| New | +$36.1M | 0.07% | 289 |
|